Skip to main content

The Schaffner Report

Schaffner Report: Are We on Track to End the COVID-19 Pandemic?

Although the US may have fallen short of the ambitious goal of vaccinating 70 percent of the population by July 4, 2021, those states and communities with high vaccination rates are seeing declines in cases and deaths due to COVID-19. Are we nearing the end of the pandemic, or does the Delta variant threaten the progress made thus far? In this episode of the Schaffner Report, NFID Executive Director and CEO Marla Dalton talks with NFID Medical Director William Schaffner, MD, about current issues regarding the ongoing COVID-19 pandemic …

Schaffner Report: COVID-19 Vaccine Side Effects—Cause or Coincidence?

As COVID-19 vaccination efforts continue across the US, some questions and concerns about potential side effects are also circulating. In addition to the typical sore arm and fatigue, reports have recently surfaced about individuals suffering from various symptoms after getting vaccinated, including ringing in the ears (tinnitus) and inflammation of the heart muscle (myocarditis). But just because one event follows another in time does not necessarily mean it was caused by the event itself. In this episode of the Schaffner Report, Marla Dalton, Executive Director and CEO of the National Foundation for Infectious Diseases (NFID) talks with NFID Medical Director William Schaffner, MD, about the difference between causation and coincidence, and how to distinguish COVID-19 vaccine facts from fiction …

Schaffner Report: Adolescent COVID-19 Vaccination

On May 12, 2021, the Advisory Committee on Immunization Practices recommended that the Pfizer COVID-19 vaccine be used in children age 12-15 years and provided new guidance on co-administration of COVID-19 vaccines with other recommended vaccines, including influenza. In this episode of the Schaffner Report, NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO Marla Dalton about these important new developments …

Schaffner Report: COVID-19 Vaccine Safety Update

Following a thorough safety review, FDA and CDC have determined that the recommended pause regarding the use of the Johnson & Johnson COVID-19 vaccine in the US should be lifted and use of the vaccine should resume. In this episode of the Schaffner Report, NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO Marla Dalton about the decision and how it may impact confidence in COVID-19 vaccines …

Schaffner Report: COVID-19 Vaccine Safety and Effectiveness

Recent news headlines about COVID-19 vaccines have been focused on concerns about safety and effectiveness. Public health authorities in the US and Europe are reviewing reports of a rare blood clotting disorder among some vaccine recipients, as well as rare reports of breakthrough illnesses in fully vaccinated individuals. In this episode of the Schaffner Report, NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO Marla Dalton about the significance of these reports and the implications for COVID-19 vaccination efforts in the US …

Schaffner Report: New COVID-19 Vaccine and Other ACIP Updates

The Advisory Committee on Immunization Practices (ACIP) recently held two important meetings to review data on vaccines for influenza, hepatitis, pneumococcal disease, shingles, and other diseases, and to approve the new Janssen COVID-19 vaccine. Marla Dalton, executive director and CEO of the National Foundation for Infectious Diseases (NFID), talks with NFID Medical Director William Schaffner, MD, about the significance of these meetings for healthcare professionals and the public …

Schaffner Report: COVID-19 Vaccines, Reinfection, and Masks

COVID-19 cases, hospitalizations, and deaths are starting to decline in the US, and vaccination rates are starting to increase. However, public health experts are concerned about new variants, the possibility of reinfection, and the overall risk of complacency. In this episode of the Schaffner Report, NFID Executive Director and CEO Marla Dalton, CAE, talks with NFID Medical Director William Schaffner, MD, about COVID-19 vaccines, masks, and reinfection …

Schaffner Report: Spread Joy, Not Germs This Holiday Season

In this edition of the Schaffner Report, William Schaffner, MD, medical director of the National Foundation for Infectious Diseases (NFID), talks with NFID Executive Director and CEO Marla Dalton, CAE, about ways to reduce risk during holiday season celebrations…

Schaffner Report: Keep Up The Rates

NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO Marla Dalton, CAE, about Keep Up The Rates, a national campaign focused on encouraging all individuals to receive recommended vaccines that may have been delayed due to the COVID-19 pandemic…

Schaffner Report: Safely Navigating Outdoor Spaces During COVID-19

Summer is normally a time to enjoy the great outdoors. But in the era of COVID-19, is it safe to go to parks, beaches, pools, or other crowded places? What can individuals do to enjoy summer fun without contracting the novel coronavirus? NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO, Marla Dalton, CAE, about ways to reduce risk and enjoy outdoor summer activities in a COVID-19 environment…

Schaffner Report: Hepatitis Edition

NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO, Marla Dalton, CAE, about the differences between hepatitis A, B, and C and steps that individuals can take to help protect themselves

Schaffner Report: #COVID-19 Face Masks

Citing recent studies on asymptomatic transmission, CDC recommends that the general public wear cloth face coverings in public settings like grocery stores and pharmacies, where social distancing may be hard to maintain. NFID Medical Director William Schaffner, MD discusses the rationale for the updated guidance and what the public should know about wearing face masks…